United States District Court for the Northern District of Illinois · 2005-08-12
15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)
Case and law context
Role: rule-announced; posture: civil; putative class action by independent pharmacies against pharmacy benefits manager; after denial of 12(b)(6), defendant's Rule 16 issue-narrowing motion to fix rule of reason (not per se) as the standard for Claim I; granted; result: not-decided; claim:
Uncertainty
None recorded
Misfit
v1 records a mode-of-analysis ruling as rule-announced / not-reached, which stops it being read as a finding, but WHICH mode was selected (rule of reason for Claim I; per se conceded-if-proved for Claim II) lives only in gloss and variant text. There is no structured "mode-selected: <mode>" value, and two blocks under the same id restraint.per-se here point in opposite directions.
The case-level role is rule-announced, so every block inherits it and must carry a `rule` quote; bare not-reached blocks (and restraint.rule-of-reason, which is the standard actually selected but has no quote of its own) had to be given `role background` to pass the checker. "Element not touched in a rule-announcing opinion" has no role value.
Rule 16 issue-narrowing is a posture with no natural result: no claim is won, lost or remanded; `not-decided` is the closest, yet a significant legal ruling against the claimant was made.
The facts are a hybrid of complaint allegations and "undisputed facts in the parties' submissions" plus agency reports (FTC statement, FTC/DOJ report) taken as legislative facts; a not-reached block carries no basis, so the epistemic status of its fact lines (alleged / undisputed / legislative) is unrecorded.
The defendant (Caremark) is not itself a party to the horizontal agreement in Claim I; it is the agent/hub of an agreement among non-party Plan Sponsors. The notation cannot express hub-vs-spoke roles or that the conspirators are non-parties.
The procompetitive-justification / ancillarity analysis (efficiencies of the larger venture) is the heart of the opinion; it has no element of its own and is folded into restraint.per-se as the reason per se treatment fails.
The `rule` under agreement is the court applying Masonite, with the citation embedded in the sentence; rule lines that are citation sentences are noisy for the law side.
B · Case × element grid
Top-level elements follow claim order in panels of up to six elements. Case rows repeat across panels. Every recorded block retains its holding and basis; multiple blocks are not merged into a case-level verdict. ✓ satisfied · ✗ not satisfied · ○ not reached · · not addressed. Muted blocks are not counted. Sub-element evidence remains on case and element pages.
Elements 1–6 of 11
Elements 7–11 of 11
| Case | Statute of limitations (4-year civil under 15 U.S.C. § 15b; 5-year criminal under 18 U.S.C. § 3282) | Law-of-the-case doctrine in consolidated/MDL antitrust proceedings | Criminal mens rea: knowing participation in the conspiracy or intent to restrain trade | Ancillary restraints doctrine (restraint subordinate and collateral to a legitimate productive integration) | Horizontal cartel / hub-and-spoke conspiracy operating through vertical or dual-distribution arrangements |
|---|---|---|---|---|---|
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | · not addressed | · not addressed | · not addressed | · not addressed | · not addressed |
Instances and excluded annotation blocks
| Case | Element | Holding and scope | Pattern | Exact source quotations |
|---|---|---|---|---|
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 — satisfied · pleaded (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | Concerted action ("contract, combination ... or conspiracy") between separate economic decisionmakers | satisfied Counted merits instance applied / merits basis: pleaded; count: Claim I; subject: count=Claim I Court rejects the characterisation of 1,200 separate vertical contracts: the relevant agreement is the horizontal one among the spokes (pleading sufficiency was decided earlier by adopting the transferor court's opinion). | buyers-knowingly-sharing-common-purchasing-agent | Claim I asserts a conspiracy between Plan Sponsors, using Caremark as their “common agent,” to fix the prices paid independent pharmacies for dispensing prescription drugs to Plan Subscribers.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [6180:6372] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.Under United States v. Masonite Corp., 316 U.S. 265, 276, 62 S.Ct. 1070, 86 L.Ed. 1461 (1942) the Plan Sponsors’ knowledge of and acquiescence in that common strategy could reasonably support a finding of conspiracy under Section 1.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [11894:12126] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.For purposes of Pharmacy’s common agent claim, the relevant agreement is that alleged to exist among the Plan Sponsors. And that agreement, between firms that would normally compete with each other for the purchase of prescription drugs, may fairly be said to constitute a horizontal restraint.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [12421:12715] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9. |
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 — not reached (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | Restraint of trade or commerce among the several States or with foreign nations | not_reached Excluded from merits counts rule-announced / merits | Unspecified route | No source quotation recorded for this block. |
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 — not reached (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | Private antitrust injury and fact of damage (Clayton Act §§ 4, 16; Brunswick Corp. v. Pueblo Bowl-O-Mat) | not_reached Excluded from merits counts rule-announced / merits | Unspecified route | No source quotation recorded for this block. |
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 — not reached (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | Relevant product/geographic market definition and market power under the Rule of Reason | not_reached Excluded from merits counts rule-announced / meritsMarket power is necessary under the rule of reason but cannot convert a restraint into a per se violation; whether Caremark has it is not decided. | Unspecified route | there appears to be no authority (and indeed none is found in the cases North Jackson cites) to support the notion that substantial market power is a sufficient, rather than a necessary, basis for finding that a given restraint is per se unlawful under Section 1Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [29159:29421] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9. |
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 — not reached (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | Per se illegality for naked restraints manifestly anticompetitive and lacking redeeming virtue | not_reached Excluded from merits counts rule-announced / merits party: Caremark and rival PBMs; count: Claim II; subject: party=Caremark and rival PBMs; count=Claim II Only the mode of analysis is conceded, and only conditionally ("if proved"); existence of the PBM-PBM agreement is untested, so nothing is satisfied. The rule line is the court's general statement that naked restraints get per se treatment; its second sentence is the ancillary-restraint rule the court applies to Claim I. | competing-intermediaries-fixing-reimbursement-rates | Claim II charges a conspiracy between Caremark and PBMs with which it competes to fix those same prices.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [6373:6477] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.Naked restraints are unlikely to have any redeeming value and so are usually accorded per se treatment. But ancillary restraints that “may contribute to the success of a cooperative venture that promises greater productivity and output” (id. at 189) demand the more thorough analysis provided by the rule of reason.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [16295:16610] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.Caremark implicitly concedes that the conspiracy alleged in Claim II — ’that between Caremark and other PBMs to fix drug prices — would if proved constitute a naked horizontal price-fixing agreement subject to per se treatment.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [8548:8775] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9. |
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 — not reached (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | Per se illegality for naked restraints manifestly anticompetitive and lacking redeeming virtue | not_reached Excluded from merits counts rule-announced / merits party: Plan Sponsors, acting through Caremark as their common agent; count: Claim I (common-agent claim); subject: party=Plan Sponsors, acting through Caremark as their common agent; count=Claim I (common-agent claim) Buyer-side price setting by competing payors through a shared intermediary is a real horizontal restraint, but it is bundled with claims processing, formularies, rebates and network building, and its immediate effect is lower consumer prices; the per se label in the complaint does not bind the court. Mode of analysis only: per se treatment is refused and the rule of reason selected for Claim I; whether the restraint is unreasonable is expressly left open, so this is not a not-satisfied finding. Polarity here is relative to "per se treatment applies". The court's general naked-vs-ancillary rule sentence (@16295) is filed under the Claim II block. | ancillary-restraint/cooperative-buying-through-common-agent | Over 1,200 of such Plan Sponsors have hired Care-mark to help control the cost of prescription drugs for their employees or members (“Plan Subscribers”) (SAC ¶¶15, 29).Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [3665:3833] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.In return for inclusion in Caremark’s network and access to the large volume of business that such inclusion brings, North Jackson must agree to dispense drugs to Plan Subscribers at a discount from prices charged to its cash-paying customers (SAC ¶ 30).Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [4612:4866] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.By negotiating prescription drug reimbursement rates on behalf of the 1,200 Plan Sponsors it represents, Caremark acts on behalf of what is essentially a cooperative purchasing group.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [13830:14013] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.Caremark specializes in various functions of benefit plan administration and is likely able to achieve economies of scale in the performance of those functions that would otherwise be unavailable to Plan Sponsors.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [22123:22336] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.And the creation of retail pharmacy networks, which necessarily involves the setting of reimbursement rates, undoubtedly contributes to the success of that larger endeavor.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [22337:22509] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.But where in contrast buyers join together in a productive venture, cooperative buying is rarely viewed as a per se unlawful restraint under Section 1 so long as it contributes to the productive enterprise.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [18624:18830] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.And because the alleged anticompetitive agreement between Plan Sponsors is ancillary to that arrangement, it will be assessed under the more probing analysis offered by the rule of reason.Source: docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [24868:25056] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9. |
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 — not reached (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | Presumptive Rule of Reason burden-shifting analysis (antitrust market + anticompetitive effect vs procompetitive justification) | not_reached Excluded from merits counts rule-announced / merits count: Claim I; subject: count=Claim I Selected as the governing standard for Claim I (the selection itself is recorded in the restraint.per-se Claim I block); the court expressly withholds any view on ultimate lawfulness. | Unspecified route | No source quotation recorded for this block. |
| North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 — not reached (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md)) | Antitrust standing / efficient enforcer test (Associated General Contractors; Illinois Brick) | not_reached Excluded from merits counts rule-announced / merits | Unspecified route | No source quotation recorded for this block. |
Court interpretations recorded from this case
interpretation
there appears to be no authority (and indeed none is found in the cases North Jackson cites) to support the notion that substantial market power is a sufficient, rather than a necessary, basis for finding that a given restraint is per se unlawful under Section 1
North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md))
there appears to be no authority (and indeed none is found in the cases North Jackson cites) to support the notion that substantial market power is a sufficient, rather than a necessary, basis for finding that a given restraint is per se unlawful under Section 1Source:
docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [29159:29421] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.Under the Rule of Reason (absent direct proof of actual detrimental effects on price or output under FTC v. Indiana Federation of Dentists, 476 U.S. 447 (1986)), plaintiff must define a relevant product and geographic market and prove defendants possess market power within it.
interpretation
Naked restraints are unlikely to have any redeeming value and so are usually accorded per se treatment. But ancillary restraints that “may contribute to the success of a cooperative venture that promises greater productivity and output” (id. at 189) demand the more thorough analysis provided by the rule of reason.
North Jackson Pharmacy, Inc. v. Caremark Rx, Inc. — 385 F. Supp. 2d 740 (2005) · United States District Court for the Northern District of Illinois · 2005 (15usc1: author: Fable · QA: PASS (QA1, neov2/qa/cases-v1-QA1.md))
Naked restraints are unlikely to have any redeeming value and so are usually accorded per se treatment. But ancillary restraints that “may contribute to the success of a cooperative venture that promises greater productivity and output” (id. at 189) demand the more thorough analysis provided by the rule of reason.Source:
docroot/ir/caselaw/f_supp_2d_385.jsonl#/f-supp-2d/385/0740-01; Unicode character offsets [16295:16610] (end exclusive); SHA-256 061c34d0b500376f04d011b5ab2e2f1ac60dba2bb321f15089be5be4b7c5e5d9.Distinguishes naked restraints (per se) from restraints reasonably ancillary to an efficiency-enhancing integration or cooperative venture (evaluated under the Rule of Reason), though Dagher holds core activity of a lawful integrated joint venture (setting the price of its own product) does not even implicate the ancillary-restraints inquiry.